Can Fite Biopharma Ltd ADR (CANF)

US · Healthcare · Biotechnology

$1.62+1.25%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$101,000

Revenue YoY

0.0%

Net profit

$-2.3M

Net margin

-2,277.7%

Market cap

$4.9M

Forward P/E

3.0

P/B

1.01

Book value

$2.27

EPS (TTM)

$-13.23

52-week high

$8.60

52-week low

$1.60

50-day MA

$2.26

200-day MA

$3.21

Beta

-0.02

Analysts rate Can Fite Biopharma Ltd ADR a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $8.00.

Institutions

1.88%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Can Fite Biopharma Ltd ADR — free to start.

Data updated 2026-11-07.